Your browser doesn't support javascript.
loading
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine.
Hilberink, Jacobien R; van Zeventer, Isabelle A; Chitu, Dana A; Pabst, Thomas; Klein, Saskia K; Stussi, Georg; Griskevicius, Laimonas; Valk, Peter J M; Cloos, Jacqueline; van de Loosdrecht, Arjan A; Breems, Dimitri; van Lammeren-Venema, Danielle; Boersma, Rinske; Jongen-Lavrencic, Mojca; Fehr, Martin; Hoogendoorn, Mels; Manz, Markus G; Söhne, Maaike; van Marwijk Kooy, Rien; Deeren, Dries; van der Poel, Marjolein W M; Legdeur, Marie Cecile; Tick, Lidwine; Chalandon, Yves; Ammatuna, Emanuele; Blum, Sabine; Löwenberg, Bob; Ossenkoppele, Gert J; Huls, Gerwin.
Afiliação
  • Hilberink JR; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands.
  • van Zeventer IA; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands.
  • Chitu DA; Department of Hematology, HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Pabst T; Department of Oncology, University Hospital, Inselspital, and University of Bern, Bern, Switzerland.
  • Klein SK; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands.
  • Stussi G; Department of Internal Medicine, Meander Hospital Amersfoort, Amersfoort, the Netherlands.
  • Griskevicius L; Department of Hematology, Oncology Institute of Southern Switzerland, Ospedale Regionale, Bellinzona, Switzerland.
  • Valk PJM; Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius University, Vilnius, Lithuania.
  • Cloos J; Department of Hematology, Erasmus University Medical Center and Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • van de Loosdrecht AA; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Breems D; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • van Lammeren-Venema D; Department of Hematology, ZNA Stuivenberg/Middelheim, Antwerp, Belgium.
  • Boersma R; Department of Hematology, Hagaziekenhuis, Den Haag, the Netherlands.
  • Jongen-Lavrencic M; Department of Hematology, Amphia Hospital, Breda, the Netherlands.
  • Fehr M; Department of Hematology, Erasmus University Medical Center and Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Hoogendoorn M; Department of Medical oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Manz MG; Department of Hematology, Medical Center Leeuwarden, Leeuwarden, the Netherlands.
  • Söhne M; Department of Medical Oncology and Hematology, Universitätsspital Zurich, Zurich, Switzerland.
  • van Marwijk Kooy R; Department of Hematology, Antonius Hospital, Nieuwegein, the Netherlands.
  • Deeren D; Department of Hematology, Isala Hospital, Zwolle, the Netherlands.
  • van der Poel MWM; Department of Hematology, AZ Delta Roeselare, Roeselare, Belgium.
  • Legdeur MC; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Tick L; Department of Hematology, Medical Spectrum Twente, Enschede, the Netherlands.
  • Chalandon Y; Department of hematology, Maxima Medical Center, Veldhoven, the Netherlands.
  • Ammatuna E; Division of hematology, University Hospital Genève and Faculty of Medicine, University of Genève, Genève, Switzerland.
  • Blum S; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands.
  • Löwenberg B; Service and Central Laboratory of Hematology, Department of Oncology and Department of Laboratory Medicine and Pathology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
  • Ossenkoppele GJ; Department of Hematology, Erasmus University Medical Center and Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Blood Cancer J ; 13(1): 93, 2023 06 19.
Article em En | MEDLINE | ID: mdl-37336890
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Blood Cancer J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Blood Cancer J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda